NASDAQ: BIIB - Biogen

Yield per half year: -9.66%
Sector: Healthcare

Share chart Biogen


About

Biogen Inc. — американская многонациональная биотехнологическая компания, базирующаяся в Кембридже, штат Массачусетс, специализирующаяся на открытии, разработке и поставке методов лечения нейродегенеративных, гематологических и аутоиммунных заболеваний пациентам во всем мире.


Цена ао 221.58
P/E 9.26
P/S 3.79
P/BV 4.09
EV/EBITDA 7.71
EBITDA 7.52
Сайт http://www.biogen.com
Число акций ао 0.1456 млрд
Выручка 14.38
Див.доход ао 0
ISIN US09062X1037
Change price per day: -3.69% (230.06)
Change price per week: -3.27% (229.06)
Change price per month: -4.36% (231.69)
Change price per 3 month: +13.54% (195.15)
Change price per half year: -9.66% (245.27)
Change price per year: -19.98% (276.9)
Change price per 3 year: -16.91% (266.68)
Change price per 5 year: -20.16% (277.52)
Change price per year to date: -14.11% (257.97)


All parameters ⇨

Underestimation

Title Value Grade
P/S 3.82 4
P/BV 2.54 6
P/E 32.35 5
EV/EBITDA 16.87 6
Total: 6.88

Efficiency

Title Value Grade
ROA, % 4.52 1
ROE, % 8.24 3
Total: 3.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.0871

Debt

Title Value Grade
Debt/EBITDA 2.82 4
Total: 5

Growth impulse

Title Value Grade
Yield Revenue, % -31.57 0
Yield Ebitda, % -65.43 0
Yield EPS, % -74.63 0
Total: 0

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
12.02.2024 13.02.2024 Singhal Priya
Head of Development
Sale 239.45 100 330 419 0 0 link
09.02.2024 13.02.2024 Izzar Rachid
Head of Global Product Strat.
Purchase 226.53 343 193 1515 0 0 link
09.02.2024 13.02.2024 Kramer Robin
Chief Accounting Officer
Purchase 226.53 188 699 833 0 0 link
09.02.2024 13.02.2024 MCDONNELL MICHAEL R
EVP, Chief Financial Officer
Purchase 226.53 737 808 3257 0 0 link
09.02.2024 13.02.2024 Murphy Nicole
Head of Pharm Ops and Tech
Purchase 226.53 514 676 2272 0 0 link
09.02.2024 13.02.2024 Singhal Priya
Head of Development
Purchase 226.53 274 554 1212 0 0 link
09.02.2024 13.02.2024 Gregory Ginger
EVP, Human Resources
Purchase 226.53 488 852 2158 0 0 link
08.02.2024 09.02.2024 Murphy Nicole
Head of Pharm Ops and Tech
Purchase 240.58 505 459 2101 0 0 link
08.02.2024 09.02.2024 MCDONNELL MICHAEL R
EVP, Chief Financial Officer
Purchase 240.58 561 754 2335 0 0 link
08.02.2024 09.02.2024 Kramer Robin
Chief Accounting Officer
Purchase 240.58 189 577 788 0 0 link
08.02.2024 09.02.2024 Izzar Rachid
Head of Global Product Strat.
Purchase 240.58 491 505 2043 0 0 link
08.02.2024 09.02.2024 Gregory Ginger
EVP, Human Resources
Purchase 240.58 393 348 1635 0 0 link
08.02.2024 09.02.2024 ALEXANDER SUSAN H
EVP Chief Legal Officer
Purchase 240.58 526 870 2190 0 0 link
28.04.2023 02.05.2023 Gregory Ginger
EVP, Human Resources
Sale 300 804 300 2681 0 0 link
08.12.2022 12.12.2022 Kramer Robin
Chief Accounting Officer
Purchase 289.47 101 315 350 0 0 link
27.10.2022 28.10.2022 ALEXANDER SUSAN H
EVP Chief Legal Off & Corp Sec
Sale 280.7 1 552 830 5532 0 0 link
30.08.2022 31.08.2022 BIOGEN INC.
10% Owner
Sale 5.27 527 000 100000 0 -0.07 link
29.08.2022 31.08.2022 BIOGEN INC.
10% Owner
Sale 5.33 2 132 000 400000 0 -0.27 link
01.07.2022 06.07.2022 Izzar Rachid
Head of Alzheimer's Disease
Purchase 215.98 108 854 504 0 0 link
01.07.2022 06.07.2022 Kramer Robin
Chief Accounting Officer
Purchase 215.98 54 427 252 0 0 link
07.06.2021 09.06.2021 Guindo Chirfi
Head of Glob Prod Strat & Com
Sale 440 1 358 280 3087 0 0 link
07.06.2021 09.06.2021 Sandrock Alfred
Head of Research & Development
Sale 440 3 375 680 7672 0 0 link
04.06.2021 07.06.2021 Posner Brian S
Director
Sale 274.17 98 701 360 0 0 link

Institutions Volume Share, %
PRIMECAP Management Company 16264481 11.19
Vanguard Group Inc 14407330 9.91
Blackrock Inc. 14246658 9.8
State Street Corporation 6945665 4.78
T. Rowe Price Investment Management, Inc. 5357326 3.69
Wellington Management Group, LLP 5324396 3.66
JP Morgan Chase & Company 5011319 3.45
Geode Capital Management, LLC 3309317 2.28
Invesco Ltd. 1814666 1.25
ClearBridge Investments, LLC 1679302 1.16



Head Job title Payment Year of birth
Ms. Robin C. Kramer Senior VP & Chief Accounting Officer N/A 1966 (58 years)
Ms. Natacha Gassenbach Chief Communication Officer & Head of Corporate Affairs N/A
Dr. Ginger Gregory Executive VP & Chief Human Resources Officer 1.59M 1968 (56 years)
Ms. Nicole Murphy Head of Pharmaceutical Operations & Technology 1.46M
Mr. Michael R. McDonnell CPA Executive VP & CFO 2.12M 1964 (60 years)
Ms. Susan H. Alexander Esq. Executive VP & Chief Legal Officer 2.2M 1957 (67 years)
Mr. Christopher A. Viehbacher President, CEO & Director 487.94k 1961 (63 years)
Mr. Charles E. Triano Senior VP & Head of Investor Relations N/A
Mr. Adam Keeney Ph.D. Executive VP & Head of Corporate Development N/A
Ms. Alisha A. Alaimo President & Head of North America N/A

Address: United States, Cambridge, MA , 225 Binney Street - open in Google maps, open in Yandex maps
Website: http://www.biogen.com